Can isosorbide mononitrate 30 mg extended‑release be converted to a crushable (immediate‑release) formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Crush Isosorbide Mononitrate 30mg Extended-Release

Isosorbide mononitrate 30 mg extended-release tablets should NOT be crushed or chewed and must be swallowed whole. 1

Why Crushing Is Contraindicated

The FDA-approved drug labeling explicitly states that isosorbide mononitrate extended-release tablets "should not be chewed or crushed and should be swallowed together with a half-glassful of fluid" 1. This is a critical pharmaceutical requirement, not merely a suggestion.

The Extended-Release Mechanism

The extended-release formulation is specifically designed with a controlled membrane principle where:

  • 30% of the dose is available for immediate release (providing rapid onset within 30 minutes)
  • 70% is gradually released over time to maintain therapeutic effect for up to 17 hours 1, 2

Crushing the tablet destroys this carefully engineered release mechanism, which would result in:

  • Immediate release of the entire 30 mg dose
  • Loss of the sustained 17-hour therapeutic window
  • Potential for excessive hypotension, headache, and reflex tachycardia
  • Loss of the nitrate-free interval needed to prevent tolerance development

Alternative Approaches

If the patient cannot swallow tablets, you have several evidence-based options:

1. Switch to Immediate-Release Isosorbide Mononitrate

  • Use 20 mg twice daily with doses separated by at least 7 hours to maintain a nitrate-free interval 3, 4
  • This provides 12-24 hours of effect per the ACC/AHA guidelines
  • Can be crushed if necessary (though not ideal)

2. Switch to Isosorbide Dinitrate

  • Use 5-80 mg oral tablets 2-3 times daily 3, 4
  • Duration of effect: up to 8 hours
  • More flexible dosing options

3. Use Sublingual Nitroglycerin

  • 0.3-0.6 mg sublingual tablets as needed 3, 4
  • Onset: 1-7 minutes
  • Appropriate for acute symptom relief rather than chronic prophylaxis

4. Consider Transdermal Nitroglycerin

  • 0.2-0.8 mg/hour patches applied every 12 hours (with 12-hour patch-free interval) 3, 4
  • Provides 8-12 hours of effect during intermittent therapy
  • No swallowing required

5. Intravenous Nitroglycerin (if hospitalized)

  • Start at 5-10 mcg/min, titrate by 10 mcg/min every 3-5 minutes 3, 4
  • For acute management only

Critical Tolerance Considerations

All nitrate regimens MUST include a nitrate-free interval of at least 10-14 hours daily to prevent tolerance development 3, 4. The extended-release formulation achieves this by providing high plasma concentrations for 12 hours, then allowing levels to fall (but remain protective against coronary spasm) for the remaining 12 hours 5.

Common Pitfall

Do not attempt to "convert" the extended-release dose by simply crushing it or switching to an equivalent immediate-release dose without adjusting the regimen. The 30 mg ER once daily is NOT equivalent to 30 mg immediate-release once daily—you need a twice-daily immediate-release regimen with appropriate spacing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.